Your session is about to expire
← Back to Search
Study Summary
This trial found that using Arista hemostatic powder resulted in less blood loss, fewer hematomas, and better range of motion after total knee arthroplasty, when compared to patients who did not receive the product.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
How many participants are receiving treatment within this clinical trial?
"Confirmed. Per the clinicaltrials.gov website, this medical trial is still in search of participants and was initially posted on May 1st 2021. A total of 60 people are required for completion from one single site."
To what degree is Arista hazardous to human health?
"Arista has little research-based evidence of efficacy or safety, so it was assigned a rating of 1."
Are there still openings available for enrolment in this trial?
"Verified. Clinicaltrials.gov indicates that this medical study, which kicked off on May 1st 2021, is actively seeking participants. The trial requires 60 people to be recruited from a single location."
Share this study with friends
Copy Link
Messenger